XPD D312N (A/G)

  • Product Reviews (0)
  • Citations (2)

Research Focus

Platinum agents cause DNA cross-linking and oxidative damage. Genetic polymorphisms of DNA repair genes are associated with differential DNA repair activity and are under investigations to increase the understanding of interindividual differences in overall survival after therapy with platinum agents for cancer.

Target Disease/Application

DNA repair genes polymorphisms

Assay ID dbSNP ID Location Gene Symbol Gene Name SNP Type  
C___3145050_10 rs1799793 Chr.19: 45867259 ERCC2 excision repair cross-complementing rodent repair deficiency, complementation group 2 Mis-sense Mutation


General Specifications

# of assays: 1
Technology: TaqMan® Assays - Pre-formulated assay (20x or 60x mix)
Scale: Available in multiple scales
Intended Use: Research Use Only

Kit Storage

-20° C


Citations & References (2)

  • XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy

Sarada Gurubhagavatula et al.
Journal of Clinical Oncology, Vol 22, No 13 (July 1), 2004: pp. 2594-2601
  • Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

de las Penas et al.
Annals of Oncology 17: 668–675, 2006 R.